Trial intelligence / Profile preview

Erythromycin plus low-dose isotretinoin or flutamide versus doxycycline in female severe acne vulgaris

IRCT201104094310N6Phase 3Completed

Sponsor
Ardabil University of Medical Sciences
Start
Sep 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of erythromycin, isotretinoin, flutamide and doxycycline in acne vulgaris (3 arms), sponsored by Ardabil University of Medical Sciences. Started Sep 2013; status: completed.

02

Drugs

erythromycinisotretinoinflutamidedoxycycline
03

Conditions

acne vulgaris

Beyond the preview

Go deeper on IRCT201104094310N6.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201104094310N6.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call